Adherence-enhancing interventions for highly active antiretroviral therapy in HIV-infected patients - a systematic review

HIV Medicine

Volumn 14, Issue 10, 2013, Pages 583-595

  Mathes, T ^a   Pieper, D ^a   Antoine, S L ^a   Eikermann, M ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Antiretroviral therapy; HIV; Medication adherence; Patient compliance; Systematic review

Indexed keywords

DEVELOPED COUNTRY; EMBASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICATION COMPLIANCE; MEDLINE; MORTALITY; PRIORITY JOURNAL; PSYCINFO; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VIRUS LOAD; WORLD HEALTH ORGANIZATION;

ANTIRETROVIRAL THERAPY; HIV; MEDICATION ADHERENCE; PATIENT COMPLIANCE; SYSTEMATIC REVIEW;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; MEDICATION ADHERENCE; MOTIVATIONAL INTERVIEWING; PATIENT COMPLIANCE;

EID: 84885478326     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/hiv.12051     Document Type: Review

References (49)

1. Vrijens B, Goetghebeur E, de Klerk E, Rode R, Mayer S, Urquhart J. Modelling the association between adherence and viral load in HIV-infected patients. Stat Med 2005; 24: 2719-2731.
2. Harrigan PR, Hogg RS, Dong WW etal. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis 2005; 191: 339-347.
3. Ortego C, Huedo-Medina TB, Llorca J etal. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav 2011; 15: 1381-1396.
4. Feaster DJ, Mitrani VB, Burns MJ etal. A randomized controlled trial of Structural Ecosystems Therapy for HIV medication adherence and substance abuse relapse prevention. Drug Alcohol Depend 2010; 111: 227-234.
5. Wagner GJ, Kanouse DE, Golinelli D etal. Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578). AIDS 2006; 20: 1295-1302.
6. Sterrantino G, Santoro L, Bartolozzi D, Trotta M, Zaccarelli M. Self-reported adherence supports patient preference for the single tablet regimen (STR) in the current cART era. Patient Prefer Adherence 2012; 6: 427-433.
7. Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Rilpivirin - Nutzenbewertung gemäß § 35a SGB V In: dossierbewertung. Cologne; 2012.
8. Center for Disease. Control and prevention. Vital signs: HIV prevention through care and treatment - United States. MMWR Morb Mortal Wkly Rep 2011; 60: 1618-1623.
9. World Health Organisation. Adherence to Long-Term Therapies-Evidence for action. 2003.
10. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. [updated September 2011]. The Cochrane Collaboration, 2011. Available at www.cochrane-handbook.org.
11. Mann DM, Woodward M, Muntner P, Falzon L, Kronish I. Predictors of nonadherence to statins: a systematic review and meta-analysis. Ann Pharmacother 2010; 44: 1410-1421.
12. Jackson CA, Clatworthy J, Robinson A, Horne R. Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review. Am J Gastroenterol 2010; 105: 525-539.
13. Barnett PG, Sorensen JL, Wong W, Haug NA, Hall SM. Effect of incentives for medication adherence on health care use and costs in methadone patients with HIV. Drug Alcohol Depend 2009; 100: 115-121.
14. Berger S, Schad T, von Wyl V etal. Effects of cognitive behavioral stress management on HIV-1 RNA, CD4 cell counts and psychosocial parameters of HIV-infected persons. AIDS 2008; 22: 767-775.
15. Collier AC, Ribaudo H, Mukherjee AL etal. A randomized study of serial telephone call support to increase adherence and thereby improve virologic outcome in persons initiating antiretroviral therapy. J Infect Dis 2005; 192: 1398-1406.
16. de Bruin M, Hospers HJ, van Breukelen GJP, Kok G, Koevoets WM, Prins JM. Electronic monitoring-based counseling to enhance adherence among HIV-infected patients: a randomized controlled trial. Health Psychol 2010; 29: 421-428.
17. Diiorio C, McCarty F, Resnicow K etal. Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study. AIDS Care 2008; 20: 273-283.
18. Fisher JD, Amico KR, Fisher WA etal. Computer-based intervention in HIV clinical care setting improves antiretroviral adherence: the LifeWindows Project. AIDS Behav 2011; 15: 1635-1646.
19. Golin CE, Earp J, Tien H-C, Stewart P, Porter C, Howie L. A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. J Acquir Immune Defic Syndr 2006; 42: 42-51.
20. Holstad MM, DiIorio C, Kelley ME, Resnicow K, Sharma S. Group motivational interviewing to promote adherence to antiretroviral medications and risk reduction behaviors in HIV infected women. AIDS Behav 2011; 15: 885-896.
21. Ingersoll KS, Farrell-Carnahan L, Cohen-Filipic J etal. A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV+ crack cocaine users. Drug Alcohol Depend 2011; 116: 177-187.
22. Kalichman SC, Kalichman MO, Cherry C etal. Brief behavioral self-regulation counseling for HIV treatment adherence delivered by cell phone: an initial test of concept trial. AIDS Patient Care STDS 2011; 25: 303-310.
23. Levin TR, Klibanov OM, Axelrod P etal. A randomized trial of educational materials, pillboxes, and mailings to improve adherence with antiretroviral therapy in an Inner City HIV clinic. J Clin Outcomes Manag 2006; 13: 217-221.
24. Parsons JT, Golub SA, Rosof E, Holder C. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J Acquir Immune Defic Syndr 2007; 46: 443-450.
25. Rathbun RC, Farmer KC, Stephens JR, Lockhart SM. Impact of an adherence clinic on behavioral outcomes and virologic response in treatment of HIV infection: a prospective, randomized, controlled pilot study. Clin Ther 2005; 27: 199-209.
26. Reynolds NR, Testa MA, Su M etal. Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial. J Acquir Immune Defic Syndr 2008; 47: 62-68.
27. Rosen MI, Dieckhaus K, McMahon TJ etal. Improved adherence with contingency management. AIDS Patient Care STDS 2007; 21: 30-39.
28. Ruiz I, Olry A, Lopez MA, Prada JL, Causse M. Prospective, randomized, two-arm controlled study to evaluate two interventions to improve adherence to antiretroviral therapy in Spain. Enferm Infecc Microbiol Clin 2010; 28: 409-415.
29. Safren SA, O'Cleirigh CM, Bullis JR, Otto MW, Stein MD, Pollack MH. Cognitive Behavioral Therapy for Adherence and Depression (CBT-AD) in HIV-Infected Injection Drug Users: a Randomized Controlled Trial. J Consult Clin Psychol 2012 [Epub ahead of print].
30. Simoni JM, Huh D, Frick PA etal. Peer support and pager messaging to promote antiretroviral modifying therapy in Seattle: a randomized controlled trial. J Acquir Immune Defic Syndr 2009; 52: 465-473.
31. Sorensen JL, Haug NA, Delucchi KL etal. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend 2007; 88: 54-63.
32. Webel AR. Testing a peer-based symptom management intervention for women living with HIV/AIDS. AIDS Care 2010; 22: 1029-1040.
33. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008; (16): CD000011.
34. Al-Aqeel S, Al-Sabhan J. Strategies for improving adherence to antiepileptic drug treatment in patients with epilepsy. Cochrane Database Syst Rev 2011; (19): CD008312.
35. Schedlbauer A, Davies P, Fahey T. Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev 2010; (17): CD004371.
36. Hart JE, Jeon CY, Ivers LC etal. Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review. J Acquir Immune Defic Syndr 2010; 54: 167-179.
37. Simoni JM, Pearson CR, Pantalone DW, Marks G, Crepaz N. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr 2006; 43 (Suppl 1): S23-S35.
38. Karcher H, Omondi A, Odera J, Kunz A, Harms G. Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya. Trop Med Int Health 2007; 12: 687-694.
39. Keogh-Brown MR, Bachmann MO, Shepstone L etal. Contamination in trials of educational interventions. Health Technol Assess 2007; 11: iii, ix-107.
40. Sussman JB, Hayward RA. An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials. BMJ 2010; 340: c2073.
41. Kobin AB, Sheth NU. Levels of adherence required for virologic suppression among newer antiretroviral medications. Ann Pharmacother 2011; 45: 372-379.
42. Shuter J, Sarlo JA, Kanmaz TJ, Rode RA, Zingman BS. HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95. J Acquir Immune Defic Syndr 2007; 45: 4-8.
43. Buscher A, Hartman C, Kallen MA, Giordano TP. Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naive, HIV patients. HIV Clin Trials 2011; 12: 244-254.
44. Gorenoi V, Schoenermark MP, Hagen A. Interventions for enhancing medication compliance/adherence with benefits in treatment outcomes (Structured abstract). In: Cologne: German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI); 2007.
45. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999; 21: 1074-1090.
46. Paes AH, Bakker A, Soe-Agnie CJ. Measurement of patient compliance. Pharm World Sci 1998; 20: 73-77.
47. Arnsten JH, Demas PA, Grant RW etal. Impact of Active Drug Use on Antiretroviral Therapy Adherence and Viral Suppression in HIV-infected Drug Users. J Gen Intern Med 2002; 17: 377-381.
48. Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, Antes G. Language bias in randomised controlled trials published in English and German. Lancet 1997; 350: 326-329.
49. Balfour L, Tasca GA, Kowal J etal. Development and validation of the HIV Medication Readiness Scale. Assessment 2007; 14: 408-416.